• A study to evaluate the safety and effectiveness of BNT324 and BNT327 in patients with advanced lung cancer

    Recruiting

    1 1 1
    Investigated Drugs:
    France Italy Poland Spain
  • A study of etentamig and daratumumab compared to daratumumab, lenalidomide, and dexamethasone in adults with newly diagnosed multiple myeloma not eligible for transplant

    Recruiting

    4 1 1 1
    Investigated Diseases:
    France Norway Spain
  • A study to evaluate the safety and effects of inebilizumab in children and adolescents with immunoglobulin G4-related disease

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Greece Italy Poland Spain
  • A study comparing the effectiveness and safety of datopotamab deruxtecan and docetaxel in adults with advanced or metastatic non-squamous non-small cell lung cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Austria Belgium France Germany Hungary Italy +2
  • A study evaluating the efficacy and safety of secukinumab compared to a drug combination in patients with severe Takayasu arteritis.

    Recruiting

    2 1 1 1
    France
  • Study of budesonide suppositories to treat acute radiation proctitis in men with prostate cancer

    Recruiting

    2 1 1
    Investigated Drugs:
    Austria Germany
  • A study to evaluate the use of FAPI-46 (68Ga) imaging to detect peritoneal cancer spread in patients with colorectal, gastric, ovarian, or pancreatic cancer

    Recruiting

    4 1 1
    The Netherlands Sweden
  • A study of Enzomenib in adult patients with relapsed or refractory acute leukemia, including those with MLL rearrangement or NPM1 mutation.

    Recruiting

    2 1 1
    Investigated Diseases:
    Belgium France Italy Spain
  • A study to evaluate the long-term safety and effectiveness of mRNA-3927 in patients with Propionic Acidemia

    Recruiting

    1 1 1
    Investigated Diseases:
    France The Netherlands Spain
  • A safety study of romosozumab in children and adolescents with osteogenesis imperfecta

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Germany Hungary Italy Slovakia +1

powered by